A vector-free microfluidic platform for intracellular delivery

# A vector-free microfluidic platform for intracellular delivery This page is a text version of a Portal Biotechnologies publication. The bibliographic record is labeled in the text so it can be read without the surrounding website. ## Bibliographic record - Title: A vector-free microfluidic platform for intracellular delivery - Document type: Publication - Year: 2013 - Outlet: PNAS - Cells: T cells, iPSCs, PBMCs, B cells, Monocytes, Fibroblasts, NK cells - Cargos: nanoparticle, Polymers, Antibody, siRNA, Protein, Peptide, DNA, small molecules - Page URL: https://portal.bio/publications/2013-a-vector-free-microfluidic-platform-for-intracellular-delivery--ajkHZhEAACcAc-GI - Markdown URL: https://portal.bio/publications/2013-a-vector-free-microfluidic-platform-for-intracellular-delivery--ajkHZhEAACcAc-GI.md - External publication: https://www.pnas.org/doi/abs/10.1073/pnas.1218705110 ## Summary Armon Sharei, Janet Zoldan, Andrea Adamo, +16, and Klavs F. Jensen ## Publication text Portal does not host the full text of this publication. The summary on this page and the external publication are the available sources. ## Provenance Some publications reference SQZ Biotechnologies, a company Dr. Armon Sharei and colleagues previously founded. Portal is the next generation company leveraging Dr. Sharei's platform technology.